Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
31.61
-0.06 (-0.19%)
At close: Nov 13, 2026, 4:00 PM EST
30.98
-0.63 (-1.99%)
After-hours: Nov 13, 2026, 4:37 PM EST
Surrozen Market Cap
Surrozen has a market cap or net worth of $602.54 million as of November 13, 2026. It is the 13,138th most valuable company in the world and the 2,578th biggest in the United States. Its market cap has increased by 443.25% in one year.
Market Cap
602.54M
Enterprise Value
508.02M
1-Year Change
443.25%
Global Rank
Country Rank
#2,578 United States
Category
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $602.54M, an increase of 399.40%. That is a compound annual growth rate of 31.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 602.54M | 185.98% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helus Pharma | 686.04M |
| Wave Life Sciences | 674.52M |
| Ginkgo Bioworks Holdings | 664.38M |
| Geron | 657.12M |
| Capricor Therapeutics | 652.35M |
| Crescent Biopharma | 631.53M |
| Arbutus Biopharma | 594.78M |
| Electra Therapeutics | 593.15M |